Impact of Perfusion With Methylene Blue on Perioperative Bleeding in Simultaneous Pancreas and Kidney Transplantation: A Randomized Control Trial
Authors:
- Amy HortAHAmy Hort
- Swe Zin PhyoeSPSwe Zin Phyoe
- Ahmer HameedAHAhmer Hameed
- Taina LeeTLTaina Lee
- Peter YoonPYPeter Yoon
- Lawrence YuenLYLawrence Yuen
- Chris NahmCNChris Nahm
- Natasha RogersNatasha Rogers
- Angela WebsterAWAngela Webster
- Germaine WongGWGermaine Wong
- Jerome LaurenceJLJerome Laurence
- Kerry HitosKHKerry Hitos
Open Access
- 2 July 2026
- journal article
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (8) , e1972
Abstract
Background.: Simultaneous pancreas–kidney transplantation (SPK) is the optimal treatment for selected patients with type I diabetes mellitus (T1DM) and end-stage kidney disease, but intraoperative bleeding remains a major cause of morbidity. Methylene blue flush during back-table pancreas preparation may better help preemptively identify bleeding points and reduce complications. Methods.: A single-center, single-blinded, prospective randomized control trial was conducted at Westmead Hospital over 30 mo. Sixty participants were randomized to receive either crystalloid (n = 33) or methylene blue (MB) flush (n = 27) during pancreas preparation before implantation. The primary outcome was intraoperative bleeding. Results.: There was no significant difference in intraoperative blood loss with the use of MB flush (433 ± 385 mL versus 588 ± 382 mL; P = 0.10). The MB group required significantly lower intraoperative blood transfusions (7% versus 27%, P = 0.032) but higher postoperative transfusions within 7 d (81% versus 58%, P = 0.038). No significant differences were observed in length of stay, reoperation rates, delayed graft function, readmission rates, graft loss, or mortality. Early graft loss and pancreatectomy were lower in the MB group (4% versus 12%) without reaching statistical significance ( P = 0.206). Conclusions.: MB flush did not significantly reduce intraoperative blood loss but reduced intraoperative transfusion requirements, while increasing postoperative blood transfusion requirements, indicating a temporal shift in bleeding pattern. Graft outcomes were unaffected. Further studies should explore mechanisms and evaluate long-term outcomes.Keywords
This publication has 19 references indexed in Scilit:
- A prospective, randomized, pilot trial of a polyethylene glycol (PEG)-coated collagen patch (Hemopatch®) for intraoperative hemostasis during deceased donor renal transplantCanadian Urological Association Journal, 2019
- Bleeding small bowel: methylene blue guided resectionAnz Journal of Surgery, 2018
- Use of the harmonic scalpel in cold phase recovery of the pancreas for transplantation: the westmead techniqueTransplant International, 2016
- Methylene Blue injection via superior mesenteric artery microcatheter for focused enterectomy in the treatment of a bleeding small intestinal arteriovenous malformationWorld Journal of Emergency Surgery, 2014
- Preoperative Superselective Mesenteric Angiography and Methylene Blue Injection for Localization of Obscure Gastrointestinal BleedingJAMA Surgery, 2013
- Anaphylactic reaction after methylene blue-treated plasma transfusionBritish Journal of Anaesthesia, 2011
- Thrombin generation and clot formation in methylene blue–treated plasma and cryoprecipitateTransfusion, 2009
- Methylene Blue and Vasoplegia: Who, When, and How?Mini-Reviews in Medicinal Chemistry, 2008
- Risk Factors and Impact of Delayed Graft Function after Pancreas TransplantsAmerican Journal of Transplantation, 2004
- Methylene blue‐treated fresh‐frozen plasma: what is its contribution to blood safety?Transfusion, 2003